Work

A Phase II Study of Brentuximab Vedotin Plus Adriamycin and Dacarbazine without Radiation in Non-Bulky Limited Stage Classical Hodgkin Lymphoma

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-115173

Authors: Jeremy S. Abramson, Robert A. Redd, Jeffrey A. Barnes, Elizabeth Bengtson, Ronald W. Takvorian, Lubomir Sokol, Frederick Lansigan, Philippe Armand, Bijal D. Shah, Eric D Jacobsen, Donna S Neuberg, Ann S. LaCasce, Celeste M. Bello

Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute, Dartmouth–Hitchcock Medical Center, Moffitt Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2981162599

Cites:

Cited by: 3

Related to: 10